Marker Therapeutics, Inc. (MRKR) Financials

MRKR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 14.6 million 2.4 million
March 31, 2026 17.4 million 3.6 million
Dec. 31, 2025 19.1 million 2.3 million
Sept. 30, 2025 21.7 million 3.3 million

MRKR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.7 million 374157
March 31, 2026 -1.4 million 178422
Dec. 31, 2025 -1.9 million 111131
Sept. 30, 2025 -2.7 million 33279

MRKR Net Income

No data available :(

MRKR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 11.3 million - -
March 31, 2026 14.9 million - -
Dec. 31, 2025 16.1 million - -
Sept. 30, 2025 17.6 million - -

MRKR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 19.3 million
March 31, 2026 19.3 million
Dec. 31, 2025 15.3 million
Sept. 30, 2025 16.8 million

MRKR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 1.5 million 1.1 million -
March 31, 2026 2 2.8 million 1.2 million -
Dec. 31, 2025 4 2.1 million 846606 -
Sept. 30, 2025 4 2.3 million 1.0 million -

MRKR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 2.8 million
Dec. 31, 2025 1.1 million -
Sept. 30, 2025 1.2 million 2.3 million

MRKR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MRKR

Price: $1.15

52 week price:
0.81
2.46

Earnings Per Share: -0.38 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 156064

Market Capitalization: 19.2 million

Links: